BioStream Ltd.
Digital Health — Stage: R&D. Est: 2025. Tags: Analysis, Analytics, Artificial Intelligence, Healthtech, Life Sciences, Machine Vision, Nanotechnology. BioStream is pioneering a new category of digital diagnostics, combining nano-enabled urine biomarkers with AI-powered analytics to noninvasively monitor neurological health. The company's platform seamlessly integrates a smart urine collection device and mobile app, allowing patients, especially children with CSF shunts or suspected hydrocephalus, to conduct routine, pain-free testing at home. Behind the scenes, BioStream’s proprietary nanotechnology and machine vision algorithms quantify biomarker levels, track trends and provide clinical insights to physicians via a secure portal. Broader vision: early Alzheimer’s detection and management. Building on the same sensor and analytics stack, BioStream is expanding to detect urinary signatures linked to early Alzheimer’s pathology. By pairing frequent at-home sampling with cloud-based AI, the company aims to: Spot disease earlier, Monitor progression and Support therapy optimization.. Web: https://biostream.health